UPDATE: Credit Suisse Downgrades Sucampo Pharmaceuticals On Valuation
March 02, 2015 at 09:19 AM EST
In a report published Monday, Credit Suisse analyst Ravi Mehrotra downgraded the rating on Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) ...
